248 related articles for article (PubMed ID: 27363398)
21. Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.
Tanaka Y; Tsuboi T; Watanabe H; Kajita Y; Nakatsubo D; Fujimoto Y; Ohdake R; Ito M; Atsuta N; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
J Parkinsons Dis; 2016 Oct; 6(4):811-819. PubMed ID: 27662325
[TBL] [Abstract][Full Text] [Related]
22. Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.
Sauvageau VM; Roy JP; Langlois M; Macoir J
Clin Linguist Phon; 2015 Jun; 29(6):424-40. PubMed ID: 25688915
[TBL] [Abstract][Full Text] [Related]
23. Vowel Articulation Dynamic Stability Related to Parkinson's Disease Rating Features: Male Dataset.
Gómez-Vilda P; Galaz Z; Mekyska J; Vicente JMF; Gómez-Rodellar A; Palacios-Alonso D; Smekal Z; Eliasova I; Kostalova M; Rektorova I
Int J Neural Syst; 2019 Mar; 29(2):1850037. PubMed ID: 30336711
[TBL] [Abstract][Full Text] [Related]
24. Speech rate in Parkinson's disease: A controlled study.
Martínez-Sánchez F; Meilán JJ; Carro J; Gómez Íñiguez C; Millian-Morell L; Pujante Valverde IM; López-Alburquerque T; López DE
Neurologia; 2016 Sep; 31(7):466-72. PubMed ID: 25660139
[TBL] [Abstract][Full Text] [Related]
25. Excitability of the lower-limb area of the motor cortex in Parkinson's disease.
Vacherot F; Attarian S; Eusebio A; Azulay JP
Neurophysiol Clin; 2010 Aug; 40(4):201-8. PubMed ID: 20674816
[TBL] [Abstract][Full Text] [Related]
26. [Not Available].
Grabli D
Presse Med; 2017 Mar; 46(2 Pt 1):187-194. PubMed ID: 28233705
[TBL] [Abstract][Full Text] [Related]
27. Prosodic expression and levodopa in Parkinson's disease.
Behlau M
Arq Neuropsiquiatr; 2013 Nov; 71(11):831-2. PubMed ID: 24394865
[No Abstract] [Full Text] [Related]
28. Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.
Senek M; Aquilonius SM; Askmark H; Bergquist F; Constantinescu R; Ericsson A; Lycke S; Medvedev A; Memedi M; Ohlsson F; Spira J; Westin J; Nyholm D
Eur J Clin Pharmacol; 2017 May; 73(5):563-571. PubMed ID: 28101657
[TBL] [Abstract][Full Text] [Related]
29. Emotional speech in Parkinson's disease.
Möbes J; Joppich G; Stiebritz F; Dengler R; Schröder C
Mov Disord; 2008 Apr; 23(6):824-9. PubMed ID: 18307245
[TBL] [Abstract][Full Text] [Related]
30. Articulatory Changes in Vowel Production following STN DBS and Levodopa Intake in Parkinson's Disease.
Martel Sauvageau V; Roy JP; Cantin L; Prud'Homme M; Langlois M; Macoir J
Parkinsons Dis; 2015; 2015():382320. PubMed ID: 26558134
[TBL] [Abstract][Full Text] [Related]
31. Articulatory deficits in parkinsonian dysarthria: an acoustic analysis.
Ackermann H; Ziegler W
J Neurol Neurosurg Psychiatry; 1991 Dec; 54(12):1093-8. PubMed ID: 1783924
[TBL] [Abstract][Full Text] [Related]
32. The effects of levodopa on word intelligibility in Parkinson's disease.
De Letter M; Santens P; Van Borsel J
J Commun Disord; 2005; 38(3):187-96. PubMed ID: 15748723
[TBL] [Abstract][Full Text] [Related]
33. Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa.
Esposito F; Tessitore A; Giordano A; De Micco R; Paccone A; Conforti R; Pignataro G; Annunziato L; Tedeschi G
Brain; 2013 Mar; 136(Pt 3):710-25. PubMed ID: 23423673
[TBL] [Abstract][Full Text] [Related]
34. Subthalamic Stimulation Reduces Vowel Space at the Initiation of Sustained Production: Implications for Articulatory Motor Control in Parkinson's Disease.
Sidtis JJ; Alken AG; Tagliati M; Alterman R; Van Lancker Sidtis D
J Parkinsons Dis; 2016 Mar; 6(2):361-70. PubMed ID: 27003219
[TBL] [Abstract][Full Text] [Related]
35. The effect of levodopa on vocal function in Parkinson's disease.
Sanabria J; Ruiz PG; Gutierrez R; Marquez F; Escobar P; Gentil M; Cenjor C
Clin Neuropharmacol; 2001; 24(2):99-102. PubMed ID: 11307045
[TBL] [Abstract][Full Text] [Related]
36. Effect of oral levodopa treatment on articulatory function in Parkinson's disease: preliminary results.
Cahill LM; Murdoch BE; Theodoros DG; Triggs EJ; Charles BG; Yao AA
Motor Control; 1998 Apr; 2(2):161-72. PubMed ID: 9644287
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of the pedunculopontine nucleus area in Parkinson's disease: effects on speech and intelligibility.
Pinto S; Ferraye M; Espesser R; Fraix V; Maillet A; Guirchoum J; Layani-Zemour D; Ghio A; Chabardès S; Pollak P; Debû B
Brain; 2014 Oct; 137(Pt 10):2759-72. PubMed ID: 25080284
[TBL] [Abstract][Full Text] [Related]
38. Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.
Picazio S; Ponzo V; Caltagirone C; Brusa L; Koch G
J Neurol; 2018 Sep; 265(9):2088-2096. PubMed ID: 29980853
[TBL] [Abstract][Full Text] [Related]
39. Quantification of the dopaminergic response in Parkinson's disease.
Müller T; Benz S
Parkinsonism Relat Disord; 2002 Jan; 8(3):181-6. PubMed ID: 12039429
[TBL] [Abstract][Full Text] [Related]
40. Concentration-effect relationship of levodopa in patients with Parkinson's disease.
Harder S; Baas H; Rietbrock S
Clin Pharmacokinet; 1995 Oct; 29(4):243-56. PubMed ID: 8549026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
